Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis

Background Multiple sclerosis (MS) has a significant inflammatory component and may have significant gray matter (GM) pathophysiology. Brain oxygenation is a sensitive measurement of the balance between metabolic need and oxygen delivery. There is evidence that inflammation and hypoxia are interdependent. In this paper, we applied novel, implanted PO2 sensors to measure hypoxia in cortical and cerebellar GM, in an inflammation-induced mouse model of MS. Objective Quantify oxygenation in cortical and cerebellar GM in the awake, unrestrained experimental autoimmune encephalomyelitis (EAE) mouse model and to relate the results to symptom level and disease time-course. Methods C57BL/6 mice were implanted with a fiber-optic sensor in the cerebellum (n = 13) and cortex (n = 24). Animals were induced with stimulation of the immune response and sensitization to myelin oligodendrocyte glycoprotein (MOG). Controls did not have MOG. We measured PO2 in awake, unrestrained animals from pre-induction (baseline) up to 36 days post-induction for EAE and controls. Results There were more days with hypoxia than hyperoxia (cerebellum: 34/67 vs. 18/67 days; cortex: 85/112 vs. 22/112) compared to time-matched controls. The average decline in PO2 on days that were significantly lower than time-matched controls was -8.8±6.0 mmHg (mean ± SD) for the cerebellum and -8.0±4.6 for the cortex. Conversely, the average increase in PO2 on days that were significantly hyperoxic was +3.2±2.8 mmHg (mean ± SD) for the cerebellum and +0.8±2.1 for the cortex. Cortical hypoxia related to increased behavioral deficits. Evidence for hypoxia occurred before measurable behavioral deficits. Conclusions A highly inflammatory condition primed to a white matter (WM) autoimmune response correlates with significant hypoxia and increased variation in oxygenation in GM of both cerebellum and cortex in the mouse EAE model of MS.

[1]  Xavier Golay,et al.  Cause and prevention of demyelination in a model multiple sclerosis lesion , 2016, Annals of neurology.

[2]  Runze Yang,et al.  Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method , 2015, Scientific Reports.

[3]  B. Trapp,et al.  Pathological mechanisms in progressive multiple sclerosis , 2015, The Lancet Neurology.

[4]  B. Trapp,et al.  Progressive multiple sclerosis 1 Pathological mechanisms in progressive multiple sclerosis , 2015 .

[5]  Ricarda Diem,et al.  Neurological deficits caused by tissue hypoxia in neuroinflammatory disease , 2013, Annals of neurology.

[6]  J. Dunn,et al.  Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination , 2013, Multiple sclerosis.

[7]  Ondrej Dolezal,et al.  Clinical correlates of grey matter pathology in multiple sclerosis , 2012, BMC Neurology.

[8]  Allan MacKenzie-Graham,et al.  Cortical atrophy in experimental autoimmune encephalomyelitis: In vivo imaging , 2012, NeuroImage.

[9]  R. Reynolds,et al.  Increased expression of ER stress- and hypoxia-associated molecules in grey matter lesions in multiple sclerosis , 2012, Multiple sclerosis.

[10]  Henry Rusinek,et al.  Characterizing Brain Oxygen Metabolism in Patients with Multiple Sclerosis with T2-Relaxation-Under-Spin-Tagging MRI , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  V. Yong,et al.  A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis , 2012, Journal of Neuroinflammation.

[12]  P. Matthews,et al.  Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability , 2011, Multiple sclerosis.

[13]  M. Calabrese,et al.  The predictive value of gray matter atrophy in clinically isolated syndromes , 2011, Neurology.

[14]  P. Fagenholz,et al.  Hypoxia and inflammation. , 2011, The New England journal of medicine.

[15]  Jeff F. Dunn,et al.  A method for measuring brain partial pressure of oxygen in unanesthetized unrestrained subjects: The effect of acute and chronic hypoxia on brain tissue PO2 , 2010, Journal of Neuroscience Methods.

[16]  Arthur W. Toga,et al.  Purkinje cell loss in experimental autoimmune encephalomyelitis , 2009, NeuroImage.

[17]  M. Karin,et al.  Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.

[18]  R. Rudick,et al.  Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.

[19]  David H. Miller,et al.  Gray matter atrophy is related to long‐term disability in multiple sclerosis , 2008, Annals of neurology.

[20]  W. Kaelin,et al.  Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.

[21]  S. Rocha,et al.  Regulation of hypoxia-inducible factor-1α by NF-κB , 2008, The Biochemical journal.

[22]  A. Windebank,et al.  Increased Expression of Endoplasmic Reticulum Stress-Related Signaling Pathway Molecules in Multiple Sclerosis Lesions , 2008, Journal of neuropathology and experimental neurology.

[23]  G. Johnson,et al.  Perfusion Magnetic Resonance Imaging Correlates of Neuropsychological Impairment in Multiple Sclerosis , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  C R G Guttmann,et al.  Thalamic atrophy and cognition in multiple sclerosis , 2007, Neurology.

[25]  Marco Battaglini,et al.  Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. , 2007, Archives of neurology.

[26]  Glyn Johnson,et al.  Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. , 2007, Archives of neurology.

[27]  P. Ratcliffe,et al.  Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay. , 2007, The Biochemical journal.

[28]  J. Nielsen,et al.  Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity , 2006, Proceedings of the National Academy of Sciences.

[29]  Arthur W. Toga,et al.  Cerebellar cortical atrophy in experimental autoimmune encephalomyelitis , 2006, NeuroImage.

[30]  Jean-Marc Constans,et al.  Reduced thalamic and cerebellar rest metabolism in relapsing–remitting multiple sclerosis, a positron emission tomography study: Correlations to lesion load , 2006, Journal of the Neurological Sciences.

[31]  D. Pham‐Dinh,et al.  Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat , 2006, Experimental Neurology.

[32]  D. Lübbers,et al.  Behavior of microflow and localPO2 of the brain cortex during and after direct electrical stimulation , 1976, Pflügers Archiv.

[33]  J. Nielsen,et al.  Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Semenza,et al.  Regulation of gene expression by HIF-1. , 2006, Novartis Foundation symposium.

[35]  S. Shapiro,et al.  An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  J. W. Lindsey EAE: History, Clinical Signs, and Disease Course , 2005 .

[37]  H. Lassmann,et al.  Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? , 2005, Acta Neuropathologica.

[38]  R. Buxton,et al.  Modeling the hemodynamic response to brain activation , 2004, NeuroImage.

[39]  M R Symms,et al.  Abnormalities of cerebral perfusion in multiple sclerosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[40]  N. De Stefano,et al.  Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment , 2004, Neurology.

[41]  F. Aktan iNOS-mediated nitric oxide production and its regulation. , 2004, Life sciences.

[42]  David H. Miller,et al.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.

[43]  R. Reynolds,et al.  Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult , 2003, Brain pathology.

[44]  K. Kivirikko,et al.  Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor* , 2003, Journal of Biological Chemistry.

[45]  R. Jaenisch,et al.  HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.

[46]  B. Brüne,et al.  NO and TNF-α released from activated macrophages stabilize HIF-1α in resting tubular LLC-PK1 cells , 2003 .

[47]  K. Jellinger,et al.  Preferential Loss of Myelin‐Associated Glycoprotein Reflects Hypoxia‐Like White Matter Damage in Stroke and Inflammatory Brain Diseases , 2003, Journal of neuropathology and experimental neurology.

[48]  R. Jaenisch,et al.  HIF-1alpha is essential for myeloid cell-mediated inflammation. , 2003, Cell.

[49]  B. Brüne,et al.  NO and TNF-alpha released from activated macrophages stabilize HIF-1alpha in resting tubular LLC-PK1 cells. , 2003, American journal of physiology. Cell physiology.

[50]  J. Geng,et al.  NF-kappaB activation for constitutive expression of VCAM-1 and ICAM-1 on B lymphocytes and plasma cells. , 2001, Biochemical and biophysical research communications.

[51]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[52]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[53]  G. Semenza HIF-1 and mechanisms of hypoxia sensing. , 2001, Current opinion in cell biology.

[54]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[55]  M. Blinkenberg,et al.  Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS , 2000, Neurology.

[56]  J R Griffiths,et al.  The OxyLite: a fibre-optic oxygen sensor. , 1999, The British journal of radiology.

[57]  S. Kondo,et al.  Clinical significance of reduced cerebral metabolism in multiple sclerosis: A combined PET and MRI study , 1998, Annals of nuclear medicine.

[58]  F. Fazio,et al.  Functional Basis of Memory Impairment in Multiple Sclerosis: A [18F]FDG PET Study , 1996, NeuroImage.

[59]  G. Semenza,et al.  General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. W. Adams,et al.  Perivascular iron deposition and other vascular damage in multiple sclerosis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[61]  J. Dunn Metabolic adjustments to acute hypoxia in the African lungfish and rainbow trout , 1985 .

[62]  J Marshall,et al.  Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[63]  J. Mussini,et al.  [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

[64]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.